» Articles » PMID: 11376906

A New Model of Visceral Pain and Referred Hyperalgesia in the Mouse

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2001 May 30
PMID 11376906
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

The generation of transgenic mice that lack or overexpress genes relevant to pain is becoming increasing common. However, only one visceral pain model, the writhing test, is widely used in mice. Here we describe a novel model, chemical stimulation of the colon, which we have developed in mice. Mice of either sex were injected i.v. with 30 mg/kg Evan's Blue for subsequent determination of plasma extravasation. For behavioural testing, they were placed on a raised grid and 50 microl of saline, mustard oil (0.25-2.5%) or capsaicin (0.03-0.3%) was administered by inserting a fine cannula into the colon via the anus. Visceral pain-related behaviours (licking abdomen, stretching, contractions of abdomen etc) were counted for 20 min. Before intracolonic administration, and 20 min after, the frequency of withdrawal responses to the application of von Frey probes to the abdomen was tested. The colon was removed post-mortem and the Evan's Blue content measured. Mustard oil and capsaicin administration evoked dose-dependent visceral pain behaviours, referred hyperalgesia (significant increase in responses to von Frey hairs) and colon plasma extravasation. The peak behavioural responses were evoked by 0.1% capsaicin and by 1% mustard oil respectively. The nociceptive behavioural responses were dose-dependently reversed by morphine (ED50 = 1.9 +/- 1 mg/kg s.c.). We conclude that this model represents a useful tool both for phenotyping mutant mice and for classical pharmacology since information on visceral pain, referred hyperalgesia and colon inflammation can all obtained from the same animal.

Citing Articles

B-cell and plasma cell activation in a mouse model of chronic muscle pain.

Lenert M, Green A, Merriwether E, Burton M Neurobiol Pain. 2024; 16:100169.

PMID: 39507010 PMC: 11539501. DOI: 10.1016/j.ynpai.2024.100169.


Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5.

Choi N, Ko S, Nam J, Choi W, Lee J, Nah S Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338333 PMC: 11435028. DOI: 10.3390/ph17091170.


Systemic administration of Resolvin D1 reduces cancer-induced bone pain in mice: Lack of sex dependency in pain development and analgesia.

Flippen A, Khasabova I, Simone D, Khasabov S Cancer Med. 2024; 13(15):e70077.

PMID: 39101490 PMC: 11299078. DOI: 10.1002/cam4.70077.


Characterization and Therapeutic Potential of Curcumin-Loaded Cerium Oxide Nanoparticles for Interstitial Cystitis Management.

Lin Y, Liang Y, Zhang C, Liu L, Lin F Antioxidants (Basel). 2024; 13(7).

PMID: 39061895 PMC: 11273629. DOI: 10.3390/antiox13070826.


Koidz Alleviates Symptoms in Zymosan-Induced Irritable Bowel Syndrome Mouse Model through TRPV1, NaV1.5, and NaV1.7 Channel Modulation.

Choi N, Choi W, Lee J, Park J, Kim Y, Das R Nutrients. 2024; 16(11).

PMID: 38892616 PMC: 11174792. DOI: 10.3390/nu16111683.